
Cravatex (CRAVATEX) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
605.2M
Gross Profit
242.7M
40.11%
Operating Income
1.0M
0.17%
Net Income
14.4M
2.39%
Balance Sheet Metrics
Total Assets
1.4B
Total Liabilities
342.8M
Shareholders Equity
1.1B
Debt to Equity
0.32
Cash Flow Metrics
Revenue & Profitability Trend
Cravatex Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 1.7B | 2.0B | 5.0B | 5.9B | 5.3B |
Cost of Goods Sold | 1.1B | 1.4B | 3.6B | 4.1B | 3.6B |
Gross Profit | 679.2M | 634.6M | 1.4B | 1.8B | 1.7B |
Gross Margin % | 39.1% | 31.3% | 28.2% | 30.6% | 31.4% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 118.9M | 378.2M | 415.4M | 483.4M |
Other Operating Expenses | 425.3M | 263.1M | 647.7M | 719.1M | 576.6M |
Total Operating Expenses | 425.3M | 382.0M | 1.0B | 1.1B | 1.1B |
Operating Income | -31.7M | -94.1M | -430.7M | -193.5M | -276.5M |
Operating Margin % | -1.8% | -4.6% | -8.6% | -3.3% | -5.2% |
Non-Operating Items | |||||
Interest Income | - | 27.7M | 16.3M | 9.8M | 12.2M |
Interest Expense | 4.0M | 4.0M | 133.6M | 134.8M | 143.2M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 63.7M | 61.6M | 583.3M | -185.4M | -297.5M |
Income Tax | 15.4M | 13.3M | -6.0M | 13.4M | 8.6M |
Effective Tax Rate % | 24.2% | 21.6% | -1.0% | 0.0% | 0.0% |
Net Income | 48.3M | 48.3M | 589.3M | -198.9M | -306.1M |
Net Margin % | 2.8% | 2.4% | 11.7% | -3.3% | -5.8% |
Key Metrics | |||||
EBITDA | 82.5M | 85.4M | -162.5M | 58.1M | 33.1M |
EPS (Basic) | - | ₹18.68 | ₹228.05 | ₹-76.96 | ₹-118.45 |
EPS (Diluted) | - | ₹18.68 | ₹228.05 | ₹-76.96 | ₹-118.45 |
Basic Shares Outstanding | - | 2584160 | 2584160 | 2584160 | 2584160 |
Diluted Shares Outstanding | - | 2584160 | 2584160 | 2584160 | 2584160 |
Income Statement Trend
Cravatex Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 752.1M | 736.4M | 562.9M | 379.2M | 352.5M |
Short-term Investments | 165.9M | 104.6M | 46.2M | 46.1M | 155.7M |
Accounts Receivable | 239.6M | 138.5M | 262.1M | 1.3B | 1.4B |
Inventory | 114.8M | 106.7M | 290.4M | 943.4M | 850.0M |
Other Current Assets | 22.7M | 651.0K | 72.7M | 1.0K | -1.0K |
Total Current Assets | 1.3B | 1.2B | 1.3B | 2.9B | 3.0B |
Non-Current Assets | |||||
Property, Plant & Equipment | 43.9M | 39.0M | 80.0K | 232.9M | 317.7M |
Goodwill | 68.0K | 1.1M | 2.7M | 213.1M | 250.3M |
Intangible Assets | 68.0K | 1.1M | 2.7M | 213.1M | 250.3M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 368.0K | -1.0K | -3.0K | -2.0K | -2.0K |
Total Non-Current Assets | 93.6M | 93.6M | 106.8M | 699.7M | 831.5M |
Total Assets | 1.4B | 1.2B | 1.4B | 3.6B | 3.9B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 125.6M | 95.6M | 212.6M | 401.4M | 229.7M |
Short-term Debt | - | 4.8M | 8.2M | 689.8M | 775.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 2.0M | 736.0K | 947.0K | 619.1M | 754.7M |
Total Current Liabilities | 310.9M | 225.2M | 426.4M | 2.1B | 2.2B |
Non-Current Liabilities | |||||
Long-term Debt | - | 23.5M | 13.5M | 1.2B | 1.1B |
Deferred Tax Liabilities | - | 0 | 0 | 7.5M | 8.3M |
Other Non-Current Liabilities | 3.2M | 2.4M | 236.0K | 39.3M | 45.3M |
Total Non-Current Liabilities | 31.9M | 32.9M | 16.5M | 1.3B | 1.2B |
Total Liabilities | 342.8M | 258.2M | 443.0M | 3.4B | 3.4B |
Equity | |||||
Common Stock | 25.8M | 25.8M | 25.8M | 25.8M | 25.8M |
Retained Earnings | - | 794.0M | 627.2M | -403.4M | -201.6M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.1B | 987.2M | 923.6M | 254.7M | 469.6M |
Key Metrics | |||||
Total Debt | 0 | 28.3M | 21.7M | 1.9B | 1.8B |
Working Capital | 1.0B | 926.6M | 833.4M | 891.3M | 853.0M |
Balance Sheet Composition
Cravatex Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 63.7M | 61.6M | 583.3M | -185.4M | -297.5M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -32.7M | 281.6M | 823.7M | -313.5M | 70.2M |
Operating Cash Flow | -32.2M | 292.0M | 1.5B | -409.1M | -127.8M |
Investing Activities | |||||
Capital Expenditures | -17.8M | -10.1M | 381.5M | -17.1M | -26.8M |
Acquisitions | - | - | - | - | - |
Investment Purchases | -78.0M | -58.4M | -262.0K | - | - |
Investment Sales | 22.1M | 125.0K | 757.0K | 111.5M | 193.9M |
Investing Cash Flow | -37.4M | -32.4M | 417.0M | 129.4M | 198.6M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -7.8M | -3.9M | -7.8M | -7.8M | -2.6M |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | -7.8M | -3.9M | -750.1M | -104.0M | -8.7M |
Free Cash Flow | 12.1M | 180.4M | 1.4B | -92.7M | -65.0M |
Net Change in Cash | -77.3M | 255.7M | 1.2B | -383.6M | 62.1M |
Cash Flow Trend
Cravatex Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
24.45
Price to Book
1.11
Price to Sales
0.66
Profitability Ratios
Profit Margin
2.69%
Operating Margin
-2.91%
Return on Equity
4.71%
Return on Assets
1.36%
Financial Health
Current Ratio
4.22
Debt to Equity
2.21
Beta
0.03
Per Share Data
EPS (TTM)
₹18.69
Book Value per Share
₹411.84
Revenue per Share
₹695.45
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
cravatex | 1.2B | 24.45 | 1.11 | 4.71% | 2.69% | 2.21 |
Wonderla Holidays | 37.4B | 37.61 | 2.17 | 6.34% | 21.72% | 0.31 |
Nicco Parks | 5.0B | 22.35 | 4.66 | 20.93% | 13.70% | 0.00 |
Ok Play India | 3.7B | - | 2.48 | -0.59% | -0.50% | 73.37 |
Emerald Leisures | 3.6B | -32.15 | -4.80 | 14.40% | -70.03% | -1.81 |
Cosco (India | 976.6M | 124.84 | 1.94 | 1.55% | -0.12% | 124.02 |
Financial data is updated regularly. All figures are in the company's reporting currency.